KTTA SCHEDULE 13G/A: SEC filing
Opaleye Management Inc., Opaleye L.P., and James Silverman
Filed with the SEC on · accession 0001493152-26-050453
KTTA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 6, 2026. Opaleye Management Inc., Opaleye L.P., and James Silverman filed a joint filing agreement as an exhibit to their Schedule 13G/A regarding beneficial ownership of Pasithea Therapeutics Corp. common stock.
Summary of the filing
Opaleye Management Inc., Opaleye L.P., and James Silverman filed a joint filing agreement as an exhibit to their Schedule 13G/A regarding beneficial ownership of Pasithea Therapeutics Corp. common stock. The agreement allows the filers to submit a single combined Schedule 13D/13G statement.
Key details
✦ Ask GOAX AI about this filing — what it means for KTTA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for KTTA?
Click hereFrequently asked questions
What did KTTA file with the SEC on Nov 6, 2026?
KTTA filed a SCHEDULE 13G/A (SEC filing). Opaleye Management Inc., Opaleye L.P., and James Silverman filed a joint filing agreement as an exhibit to their Schedule 13G/A regarding beneficial ownership of Pasithea Therapeutics Corp. common stock. The agreement allows the filers to submit a single combined Schedule 13D/13G statement.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other KTTA SEC filings
Get alerts when KTTA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days